Nexteq
NXQ · AIM · Technology · mcap £22m · 42.0p
Nexteq designs and supplies specialist electronics. Its Quixant division makes computing platforms for casino gaming machines, and its Densitron division makes display and control products for broadcast, automotive and industrial customers.
| Date | Type | Announcement | Day |
|---|---|---|---|
| 09 Sep 26 | Results | Half-year Results
H1 2026 revenue down 34% to $26.7m; adjusted EBITDA swung to loss of $2.8m; FY guidance reiterated. |
−6.0% |
|
in line with Board expectations expectations Group revenue $26.7m ($40.7m)Quixant revenue $12.8m ($26.9m)Densitron revenue $13.9m ($13.8m)Adjusted EBITDA $(2.8)m ($1.9m)Adjusted loss before tax $(4.0)m ($0.9m)Net cash $(1.4)m ($25.0m)
|
|||
| 27 Aug 26 | Notice of Investor Presentation
Nexteq will host investor presentation on interim results for six months ended 30 June 2026. |
−2.0% | |
| 26 Aug 26 | Strategic new customer win for Densitron
Densitron won design win with new automotive customer for customised electric vehicle display solutions. |
+11.1% | |
|
Production commencement H2 FY2026Expected volume trajectory Materially increase over following three years
|
|||
| 05 Aug 26 | Holding | Holding(s) in Company | |
| 05 Aug 26 | Holding | Holding(s) in Company | |
| 31 Jul 26 | Director dealing | Director/PDMR Shareholding | |
| 29 Jul 26 | Mass production PO for Pro-AV display solution
Densitron received mass production purchase order for Pro-AV display solution with Tactila technology from new customer. |
+3.2% | |
|
Contract commencement H2 2026Unit delivery Incremental increase over four years
|
|||
| 28 Jul 26 | Director dealing | Director/PDMR Shareholding | |
| 24 Jul 26 | Trading Update, Board Change and Notice of Results
H1 revenue $26.7m, down 34% YoY, due to gaming division weakness; Deputy Chair retiring August 2026. |
−7.8% | |
|
in line expectations H1 revenue $26.7m ($40.7m)Densitron revenue $13.9m ($13.8m)Quixant revenue $12.7m ($26.9m)Cash position $10.7m ($28.5m)Shareholder returns H1 $8.5m
|
|||
| 06 Jul 26 | Holding | Holding(s) in Company | |
| 06 Jul 26 | Holding | Holding(s) in Company | |
| 30 Jun 26 | Routine | Grant of Options | |
| 28 May 26 | Holding | Holding(s) in Company | |
| 28 May 26 | Holding | Holding(s) in Company | |
| 28 May 26 | Holding | Holding(s) in Company | |
| 22 May 26 | Routine | Result of AGM | |
| 21 May 26 | Trading update | Trading Update
FY26 revenue now expected approximately 15% below previous market expectations due to Quixant division challenges from US tariffs and higher component costs. |
−21.4% |
|
below expectations FY26 expected revenue vs consensus approximately 15% below ($85.0m consensus)FY26 consensus market expectations - revenue $85.0mFY26 consensus market expectations - adjusted EBITDA $4.8mFY26 consensus market expectations - adjusted profit before tax $2.0m
|
|||
| 29 Apr 26 | Report and Accounts and Notice of AGM
Annual report and accounts posted; AGM scheduled for 22 May 2026. |
−0.7% | |
| 26 Mar 26 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 24 Mar 26 | Holding | Holding(s) in Company | |
| 23 Mar 26 | Holding | Holding(s) in Company | |
| 23 Mar 26 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 20 Mar 26 | Holding | Holding(s) in Company | |
| 20 Mar 26 | Holding | Holding(s) in Company | |
| 20 Mar 26 | Dividend Timetable
Final dividend of 3.9 pence per share to be paid on 29 May 2026. |
−0.7% | |
| 20 Mar 26 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 18 Mar 26 | Results | Audited Final Results
FY2025 revenue grew 4% to $90.2m; adjusted profit fell 25% to $3.6m; delayed three-year targets to 2028. |
−1.3% |
|
in line with consensus forecasts for revenue and adjusted profit before tax expectations Group Revenue $90.2m ($86.7m)Quixant Revenue $60.1m ($54.8m)Densitron Revenue $30.1m ($31.9m)Gross margin 32.8% (35.9%)Adjusted profit before tax $3.6m ($4.8m)Net cash $25.0m ($29.1m)
|
|||
| 18 Mar 26 | Routine | Transaction in Own Shares | |
| 12 Mar 26 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 09 Mar 26 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 06 Mar 26 | Holding | Holding(s) in Company | |
| 04 Mar 26 | Routine | Notice of Results Presentation | |
| 02 Mar 26 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 27 Feb 26 | Holding | Holding(s) in Company | |
| 26 Feb 26 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 24 Feb 26 | Routine | Transaction in Own Shares and Total Voting | |
| 20 Feb 26 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 19 Feb 26 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 18 Feb 26 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 16 Feb 26 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 13 Feb 26 | First Launchpad Software License Purchase Order
Nexteq secures first customer for Launchpad gaming software platform with Asian game developer. |
+3.9% | |
|
Potential annual revenue from customer $1m per year
|
|||
| 11 Feb 26 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 10 Feb 26 | Holding | Holding(s) in Company | |
| 09 Feb 26 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 06 Feb 26 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 05 Feb 26 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 02 Feb 26 | Launchpad, Nexteq’s turnkey software platform
Nexteq launches Launchpad, a turnkey software platform for land-based casino gaming, unveiled at ICE Barcelona 2026. |
−0.1% | |
| 30 Jan 26 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 29 Jan 26 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 28 Jan 26 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 21 Jan 26 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 20 Jan 26 | Director dealing | Director/PDMR Shareholding | |
| 20 Jan 26 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 19 Jan 26 | Trading Update and Notice of Results
FY25 revenue $90.2m slightly ahead of February guidance; adjusted PBT at market consensus $3.6m. |
+2.9% | |
|
slightly ahead of February guidance, in line with market consensus expectations FY25 Revenue $90.2m ($86.7m)Quixant Revenue $60.1m ($54.8m)Densitron Revenue $30.1m ($31.9m)Adjusted PBT $3.6mNet cash $25.1m ($29.1m)
|
|||
| 08 Jan 26 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 19 Dec 25 | Share Buy Back
Nexteq announces share buyback programme to repurchase up to 10 per cent of issued share capital. |
−2.1% | |
|
Maximum buyback value £5.4mMaximum shares to be repurchased 10% of issued share capitalMaximum price per share 105% of average middle market closing price for preceding five business days
|
|||
| 18 Dec 25 | Trading update | Trading Update
FY25 revenue and adjusted PBT in line with expectations; FY26 revenue guidance cut to not less than $85m due to customer consolidation. |
−13.9% |
|
in line expectations FY25 Revenue in line with consensus $86.5mFY25 Adjusted EBITDA in line with consensus $6.0mFY25 Adjusted PBT in line with consensus $3.6mFY26 Revenue Guidance not less than $85m
|
|||
| 15 Dec 25 | Holding | Holding(s) in Company | |
| 20 Nov 25 | Option Exercises and Total Voting Rights
23,337 employee share options exercised; issued share capital now 66,539,060 shares. |
+0.0% | |
| 30 Oct 25 | Board change | Appointment of new Non-Executive Director
Deborah Wilkinson appointed as Independent Non-Executive Director and Audit & Risk Committee Chair. |
+0.0% |
| 24 Oct 25 | Holding | Holding(s) in Company | |
| 13 Oct 25 | Holding | Holding(s) in Company | |
| 18 Sep 25 | Routine | Result of General Meeting | |
| 17 Sep 25 | First Mass Production Purchase Order for Brazil
Quixant secured first mass production purchase order from Brazilian state video lottery operator. |
+6.2% | |
| 10 Sep 25 | Holding | Holding(s) in Company | |
| 10 Sep 25 | Holding | Holding(s) in Company | |
| 10 Sep 25 | Results | Half-year Results
H1 2025 revenue fell 16% to $40.7m with lower gross margin, but order intake strong and cash position stable at $28.1m. |
−1.3% |
|
in line expectations Group revenue $40.7m ($48.2m)Adjusted EBITDA $1.9m ($5.8m)Group gross margin 33.1% (37.3%)Net cash $28.1m ($29.1m)Adjusted diluted EPS 1.17c (6.07c)Order intake significantly ahead of prior period
|
|||
| 02 Sep 25 | Share Buyback, Rule 9 Waiver, Notice of GM
Nexteq seeks shareholder approval for 10% share buyback authority and Rule 9 waiver at 18 September GM. |
+6.8% | |
|
Proposed buyback authority up to 5,988,515 Ordinary SharesBuyback as % of issued share capital 10%Previous buyback completed 6,653,906 Ordinary Shares (6,653,906 Ordinary Shares)
|
|||
| 20 Aug 25 | Notice of Investor Presentation
Nexteq to host investor presentation on H1 2025 results on 10 September 2025. |
+0.0% | |
| 22 Jul 25 | Trading Update and Notice of Results
H1 2025 revenue of $40.7m below prior year; H2 expected to exceed H1 with full year in line with market expectations. |
+6.4% | |
|
in line expectations H1 2025 Group revenue $40.7m ($48.2m)Quixant revenue H1 2025 $26.9m ($30.9m)Densitron revenue H1 2025 $13.8m ($17.3m)Net cash at 30 June 2025 $28.1m ($36.9m)New IP-based revenue H1 2025 $1m+Operating cash inflows H1 2025 £2.1m
|
|||
| 04 Jun 25 | ProDeck wins Best of Show award at NAB Show 2025
Nexteq's ProDeck 24 broadcast control surface wins Best of Show at NAB Show 2025 in Las Vegas. |
+1.5% | |
| 07 May 25 | Routine | Grant of Options | |
| 29 Apr 25 | Routine | Result of AGM | |
| 29 Apr 25 | AGM Statement
Chair reaffirms confidence in achieving 2025 market expectations and three-year strategic plan despite tariff uncertainty. |
+8.5% | |
|
Net cash position $30.2m2025 consensus revenue $85.5m2025 consensus adjusted EBITDA $6.0m2025 consensus adjusted PBT $3.6m
|
|||
| 03 Apr 25 | Report and Accounts and Notice of AGM
Annual report and accounts for year ended 31 December 2024 published; AGM scheduled for 29 April 2025. |
−2.4% | |
| 03 Apr 25 | Director dealing | Director/PDMR Shareholding | |
| 02 Apr 25 | Board change | Chair Appointment
Carol Thompson appointed as Non-Executive Chair with immediate effect, replacing interim chair Nick Jarmany. |
−0.8% |
| 31 Mar 25 | Routine | Change of Registered Office | |
| 19 Mar 25 | Results | Final Results
Revenue fell 24% to $86.7m amid destocking; new leadership and three-year growth plan launched. |
−6.6% |
|
Group Revenue $86.7m ($114.3m)Adjusted profit before tax $4.8m ($14.7m)Gross margin 35.9% (36.3%)Net cash $29.1m ($27.9m)Operating cashflow $13.0m ($19.8m)Proposed dividend 3.7p per share (3.3p per share)
|
|||
| 14 Mar 25 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 13 Mar 25 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 12 Mar 25 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 12 Mar 25 | Notice of Investor Presentation
Nexteq to announce full year 2024 results on 19 March 2025 with investor presentation. |
+0.0% | |
| 11 Mar 25 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 10 Mar 25 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 06 Mar 25 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 26 Feb 25 | Capital Markets Event
Nexteq hosts capital markets event to present three-year strategic plan and organic growth targets through 2027. |
+1.4% | |
|
Revenue target (2027) $108m-$120mGross margin target (2027) 35-38%EBITDA margin target (2027) 10-15%Gaming software solution revenue target (2027) $4-5m
|
|||
| 25 Feb 25 | Routine | Transaction in Own Shares and Total Voting | |
| 24 Feb 25 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 21 Feb 25 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 20 Feb 25 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 19 Feb 25 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 07 Feb 25 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 06 Feb 25 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 05 Feb 25 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 04 Feb 25 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 03 Feb 25 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 30 Jan 25 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 29 Jan 25 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 24 Jan 25 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 23 Jan 25 | Holding | Holding(s) in Company | |
| 22 Jan 25 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 15 Jan 25 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 15 Jan 25 | Trading Update and Notice of Results
FY24 revenue $86.7m, down 24% YoY, with flat expectations for 2025 and restructuring to reduce costs. |
+1.4% | |
|
in line expectations FY24 Revenue $86.7m ($114.3m)Quixant Gaming revenue $54.8m ($69.2m)Densitron revenue $31.9m ($45.1m)Net cash $29.1m ($27.9m)Operating cost reduction (Q4 2024) $1.6mShare buyback (H2 2024) $6.7m
|
|||
| 14 Jan 25 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 13 Jan 25 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 10 Jan 25 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 09 Jan 25 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 07 Jan 25 | Holding | Holding(s) in Company | |
| 07 Jan 25 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 06 Jan 25 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 03 Jan 25 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 02 Jan 25 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 31 Dec 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 27 Dec 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 24 Dec 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 23 Dec 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 20 Dec 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 19 Dec 24 | Appointment of Director
Matt Staight appointed as Group Chief Financial Officer with immediate effect. |
+0.0% | |
| 18 Dec 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 17 Dec 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 16 Dec 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 13 Dec 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 12 Dec 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 11 Dec 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 10 Dec 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 09 Dec 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 06 Dec 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 05 Dec 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 03 Dec 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 02 Dec 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 25 Nov 24 | Routine | Transaction in Own Shares and TVR | |
| 22 Nov 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 21 Nov 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 20 Nov 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 19 Nov 24 | Holding | Holding(s) in Company | |
| 19 Nov 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 18 Nov 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 15 Nov 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 14 Nov 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 13 Nov 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 12 Nov 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 11 Nov 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 06 Nov 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 04 Nov 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 01 Nov 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 31 Oct 24 | Trading update | Trading Update and Appointment of CFO
FY24 revenue expected 10-12% below market expectations due to de-stocking and customer project delays. |
−16.9% |
|
below expectations FY24 Group revenue 10-12% below market expectationsFY24 Group adjusted profit before tax at least $6.0mNet cash balance $33m (30 September 2024)Expected year end net cash c$30mShare buyback spend to date £4.6m (c.7% of issued share capital)
|
|||
| 29 Oct 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 28 Oct 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 25 Oct 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 24 Oct 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 23 Oct 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 22 Oct 24 | Holding | Holding(s) in Company | |
| 21 Oct 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 18 Oct 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 15 Oct 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 14 Oct 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 11 Oct 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 10 Oct 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 09 Oct 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 04 Oct 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 04 Oct 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 03 Oct 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 02 Oct 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 01 Oct 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 30 Sep 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 27 Sep 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 26 Sep 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 25 Sep 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 24 Sep 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 23 Sep 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 20 Sep 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 19 Sep 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 18 Sep 24 | Holding | Holding(s) in Company | |
| 18 Sep 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 17 Sep 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 16 Sep 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 12 Sep 24 | Routine | Transaction in Own Shares and TVR | |
| 12 Sep 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 11 Sep 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 10 Sep 24 | Results | Half-year Results
H1 2024 revenue down 14% to $48.2m due to customer de-stocking; gross margin improved 310bps; net cash reached record $36.9m. |
−2.0% |
|
in line with revised expectations set out in July trading update expectations Group revenue $48.2m ($56.3m)Gross margin 37.3% (34.2%)Adjusted profit before tax $5.0m ($5.9m)Net cash $36.9m ($27.9m)Net cash from operating activities $9.9m ($6.2m)Diluted earnings per share 5.70c (6.31c)
|
|||
| 10 Sep 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 09 Sep 24 | Holding | Holding(s) in Company | |
| 09 Sep 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 06 Sep 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 05 Sep 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 03 Sep 24 | Routine | Notice of Results and Presentation | |
| 03 Sep 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 30 Aug 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 29 Aug 24 | Board change | Appointment of Chief Executive Officer
Duncan Faithfull appointed Chief Executive Officer, replacing Jon Jayal who steps down. |
+0.0% |
| 29 Aug 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 28 Aug 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 23 Aug 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 21 Aug 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 20 Aug 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 19 Aug 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 14 Aug 24 | Board change | Appointment of Interim Chair
Nick Jarmany appointed Interim Chair following Francis Small's departure; permanent Chair recruitment underway. |
+0.9% |
| 14 Aug 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 12 Aug 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 09 Aug 24 | Routine | Transaction in Own Shares | |
| 08 Aug 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 06 Aug 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 05 Aug 24 | Routine | Correction - Transaction in Own Shares and TVR | |
| 05 Aug 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 31 Jul 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 30 Jul 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 29 Jul 24 | Share Buy Back
Nexteq extends share buyback programme to purchase up to £6.5 million of shares, or 10% of issued capital. |
+4.5% | |
|
Net cash balance $36.9mMaximum buyback amount £6.5mShares to be repurchased up to 6,475,634Shares already purchased 178,272
|
|||
| 24 Jul 24 | Holding | Holding(s) in Company | |
| 24 Jul 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 24 Jul 24 | Board Transition
CEO Jon Jayal, Chair Francis Small and CFO Johan Olivier to step down; successors being identified. |
−34.7% | |
| 24 Jul 24 | Trading Update and Notice of Results
Revenue forecast cut 15-20% and profit 30-40% below expectations due to persistent customer de-stocking. |
−34.7% | |
|
below expectations H1 2024 Revenue $48.2m ($56.3m)Quixant Revenue H1 $30.9m ($34.3m)Densitron Revenue H1 $17.3m ($22.0m)Net cash $36.9m ($27.9m)FY24 Revenue guidance 15-20% below consensus $115.4mAdjusted profit before tax guidance 30-40% below consensus $14.9m
|
|||
| 23 Jul 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 17 Jul 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 16 Jul 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 15 Jul 24 | Routine | Transaction in Own Shares | |
| 09 Jul 24 | Routine | Transaction in Own Shares | |
| 04 Jul 24 | Routine | Transaction in Own Shares | |
| 02 Jul 24 | Routine | Transaction in Own Shares | |
| 01 Jul 24 | Routine | Transaction in Own Shares | |
| 28 Jun 24 | Routine | Transaction in Own Shares | |
| 26 Jun 24 | Routine | Transaction in Own Shares | |
| 21 Jun 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 20 Jun 24 | Routine | Transaction in Own Shares | |
| 17 Jun 24 | Routine | Transaction in Own Shares | |
| 13 Jun 24 | Routine | Transaction in Own Shares | |
| 11 Jun 24 | Routine | Transaction in Own Shares | |
| 07 Jun 24 | Routine | Transaction in Own Shares | |
| 04 Jun 24 | Routine | Transaction in Own Shares | |
| 03 Jun 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 29 May 24 | Routine | Transaction in Own Shares | |
| 24 May 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 22 May 24 | Routine | Transaction in Own Shares | |
| 21 May 24 | Routine | Transaction in Own Shares | |
| 20 May 24 | Routine | Transaction in Own Shares | |
| 16 May 24 | Routine | Transaction in Own Shares | |
| 15 May 24 | Routine | Transaction in Own Shares | |
| 14 May 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 10 May 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 07 May 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 02 May 24 | Routine | Grant of Options | |
| 30 Apr 24 | Holding | Holding(s) in Company | |
| 30 Apr 24 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 25 Apr 24 | Share Buyback
Nexteq announces share buyback programme of up to £1.0 million commencing today. |
+0.0% | |
|
Buyback programme size £1.0 millionMaximum price per share 105% of average middle market closing price for preceding five business days
|
|||
| 25 Apr 24 | Share Buyback
Nexteq commences limited share buyback programme of up to £1.0 million following shareholder approval. |
+0.0% | |
|
Buyback programme size £1.0 million
|
|||
| 16 Apr 24 | Routine | Result of AGM and Result of General Meeting | |
| 16 Apr 24 | AGM Statement
Nexteq confirms FY2024 market expectations with continued robust gross margins and net cash of $32.0m. |
−2.0% | |
|
in line expectations Net cash position $32.0mFY2024 revenue guidance $114.8m to $115.9mFY2024 consensus revenue $115.4mFY2024 adjusted PBT guidance $14.9m
|
|||
| 28 Mar 24 | Proposed Share Buyback and Notice of GM
Board seeks shareholder approval for share buyback authority of up to 10 per cent and Rule 9 waiver from Concert Party. |
+2.6% | |
|
Proposed buyback authority up to 6,653,906 Ordinary SharesPercentage of issued share capital 10 per centConcert Party ownership if full buyback utilised approximately 37.3 per cent
|
|||
| 22 Mar 24 | Report and Accounts and Notice of AGM
Annual report and accounts posted to shareholders; AGM scheduled for 16 April 2024. |
−0.7% | |
| 14 Mar 24 | Director dealing | Director/PDMR Shareholding, Issue of Equity & TVR | |
| 13 Mar 24 | Director dealing | Director/PDMR Share Transfers
Non-Executive Deputy Chair transferred 70,000 shares as gifts for nil consideration. |
−1.9% |
| 13 Mar 24 | Results | Final Results
FY2023 revenue down 5% to $114.3m but adjusted profit up 45% to $14.7m with record net cash of $27.9m. |
−1.9% |
|
Group Revenue $114.3m ($119.9m)Adjusted profit before tax $14.7m ($10.2m)Gross margin 36.3% (32.2%)Net cash $27.9m ($12.9m)Operating cashflow $19.8m ($0.8m)Dividend proposed 3.3p per share (3.0p per share)
|
|||
| 15 Feb 24 | Routine | Notice of Results and Presentations | |
| 09 Feb 24 | Holding | Holding(s) in Company | |
| 07 Feb 24 | Holding | Holding(s) in Company | |
| 17 Jan 24 | Trading Update and Notice of Results
FY23 adjusted profit ahead of expectations; revenues $114.8m down 4% as order book normalises; net cash up to $27.9m. |
+11.8% | |
|
ahead expectations FY23 Revenues $114.8m ($119.6m (consensus))Net cash $27.9m ($18.5m (30 June 2023))Quixant revenues $69.4m ($74.1m)Densitron revenues $45.4m ($45.4m (2022))Order book visibility c.5 months of revenues
|
|||
| 20 Oct 23 | Holding | Holding(s) in Company | |
Company filings. Not investment advice.